Select Page

Application process open for pilot phase of COIIN project

Application process open for pilot phase of COIIN project

Important Note: We extended the COIIN application deadline to August 31st. We also updated the application document and appendices, below. If you previously applied, you do not need to submit a new form. We will contact you if we need additional information.

The Collaborative Innovation and Improvement Network (COIIN) is seeking kidney transplant programs to apply as pilot test participants to employ and study effective practices to promote utilization of deceased donor kidneys, as well as alternative monitoring of transplant outcomes. The application deadline is August 31, 2016.

COIIN is a three-year study exploring an innovative approach to transplant performance monitoring that:

  • reduces the risk-avoidance behaviors that are associated with the current monitoring system
  • removes current performance flagging criteria for participating kidney transplant programs
  • develops and tests an alternative data-rich quality monitoring framework
  • supports a collaborative approach toward performance improvement and effective practices

The overall aim of the project is to increase transplantation, with a particular focus on utilization of deceased donor kidneys with a KDPI score greater than 50 percent.

The pilot study protocol has been developed by the COIIN Advisory Council, with input gathered from site visits of practice model hospitals, and a collaborative “think tank” meeting held at UNOS in June.

Fifteen to 20 deceased donor kidney transplant programs are expected to participate in each of the two study cohorts. The pilot phase will begin in October 2016 and is expected to last 12 months per cohort, spanning over an 18 month period. To qualify for participation, programs must:

  • Have performed more than 45 kidney transplants within the previous year
  • Be prepared to have program leadership and staff commit time and resources for pilot participation
  • Not be currently under MPSC outcome review for patient and/or graft survival

Please e-mail completed applications to [email protected]. For additional questions, please contact Michelle Rabold at 804-782-4667.

Share This